PNG  IHDRQgAMA a cHRMz&u0`:pQ<bKGDgmIDATxwUﹻ& ^CX(J I@ "% (** BX +*i"]j(IH{~R)[~>h{}gy)I$Ij .I$I$ʊy@}x.: $I$Ii}VZPC)I$IF ^0ʐJ$I$Q^}{"r=OzI$gRZeC.IOvH eKX $IMpxsk.쒷/&r[޳<v| .I~)@$updYRa$I |M.e JaֶpSYR6j>h%IRز if&uJ)M$I vLi=H;7UJ,],X$I1AҒJ$ XY XzI@GNҥRT)E@;]K*Mw;#5_wOn~\ DC&$(A5 RRFkvIR}l!RytRl;~^ǷJj اy뷦BZJr&ӥ8Pjw~vnv X^(I;4R=P[3]J,]ȏ~:3?[ a&e)`e*P[4]T=Cq6R[ ~ޤrXR Հg(t_HZ-Hg M$ãmL5R uk*`%C-E6/%[t X.{8P9Z.vkXŐKjgKZHg(aK9ڦmKjѺm_ \#$5,)-  61eJ,5m| r'= &ڡd%-]J on Xm|{ RҞe $eڧY XYrԮ-a7RK6h>n$5AVڴi*ֆK)mѦtmr1p| q:흺,)Oi*ֺK)ܬ֦K-5r3>0ԔHjJئEZj,%re~/z%jVMڸmrt)3]J,T K֦OvԒgii*bKiNO~%PW0=dii2tJ9Jݕ{7"I P9JKTbu,%r"6RKU}Ij2HKZXJ,妝 XYrP ެ24c%i^IK|.H,%rb:XRl1X4Pe/`x&P8Pj28Mzsx2r\zRPz4J}yP[g=L) .Q[6RjWgp FIH*-`IMRaK9TXcq*I y[jE>cw%gLRԕiFCj-ďa`#e~I j,%r,)?[gp FI˨mnWX#>mʔ XA DZf9,nKҲzIZXJ,L#kiPz4JZF,I,`61%2s $,VOϚ2/UFJfy7K> X+6 STXIeJILzMfKm LRaK9%|4p9LwJI!`NsiazĔ)%- XMq>pk$-$Q2x#N ؎-QR}ᶦHZډ)J,l#i@yn3LN`;nڔ XuX5pF)m|^0(>BHF9(cզEerJI rg7 4I@z0\JIi䵙RR0s;$s6eJ,`n 䂦0a)S)A 1eJ,堌#635RIgpNHuTH_SԕqVe ` &S)>p;S$魁eKIuX`I4춒o}`m$1":PI<[v9^\pTJjriRŭ P{#{R2,`)e-`mgj~1ϣLKam7&U\j/3mJ,`F;M'䱀 .KR#)yhTq;pcK9(q!w?uRR,n.yw*UXj#\]ɱ(qv2=RqfB#iJmmL<]Y͙#$5 uTU7ӦXR+q,`I}qL'`6Kͷ6r,]0S$- [RKR3oiRE|nӦXR.(i:LDLTJjY%o:)6rxzҒqTJjh㞦I.$YR.ʼnGZ\ֿf:%55 I˼!6dKxm4E"mG_ s? .e*?LRfK9%q#uh$)i3ULRfK9yxm܌bj84$i1U^@Wbm4uJ,ҪA>_Ij?1v32[gLRD96oTaR׿N7%L2 NT,`)7&ƝL*꽙yp_$M2#AS,`)7$rkTA29_Iye"|/0t)$n XT2`YJ;6Jx".e<`$) PI$5V4]29SRI>~=@j]lp2`K9Jaai^" Ԋ29ORI%:XV5]JmN9]H;1UC39NI%Xe78t)a;Oi Ҙ>Xt"~G>_mn:%|~ޅ_+]$o)@ǀ{hgN;IK6G&rp)T2i୦KJuv*T=TOSV>(~D>dm,I*Ɛ:R#ۙNI%D>G.n$o;+#RR!.eU˽TRI28t)1LWϚ>IJa3oFbu&:tJ*(F7y0ZR ^p'Ii L24x| XRI%ۄ>S1]Jy[zL$adB7.eh4%%누>WETf+3IR:I3Xה)3אOۦSRO'ٺ)S}"qOr[B7ϙ.edG)^ETR"RtRݜh0}LFVӦDB^k_JDj\=LS(Iv─aTeZ%eUAM-0;~˃@i|l @S4y72>sX-vA}ϛBI!ݎߨWl*)3{'Y|iSlEڻ(5KtSI$Uv02,~ԩ~x;P4ցCrO%tyn425:KMlD ^4JRxSهF_}شJTS6uj+ﷸk$eZO%G*^V2u3EMj3k%)okI]dT)URKDS 7~m@TJR~荪fT"֛L \sM -0T KfJz+nإKr L&j()[E&I ߴ>e FW_kJR|!O:5/2跌3T-'|zX ryp0JS ~^F>-2< `*%ZFP)bSn"L :)+pʷf(pO3TMW$~>@~ū:TAIsV1}S2<%ޟM?@iT ,Eūoz%i~g|`wS(]oȤ8)$ ntu`өe`6yPl IzMI{ʣzʨ )IZ2= ld:5+請M$-ї;U>_gsY$ÁN5WzWfIZ)-yuXIfp~S*IZdt;t>KūKR|$#LcԀ+2\;kJ`]YǔM1B)UbG"IRߊ<xܾӔJ0Z='Y嵤 Leveg)$znV-º^3Ւof#0Tfk^Zs[*I꯳3{)ˬW4Ւ4 OdpbZRS|*I 55#"&-IvT&/윚Ye:i$ 9{LkuRe[I~_\ؠ%>GL$iY8 9ܕ"S`kS.IlC;Ҏ4x&>u_0JLr<J2(^$5L s=MgV ~,Iju> 7r2)^=G$1:3G< `J3~&IR% 6Tx/rIj3O< ʔ&#f_yXJiގNSz; Tx(i8%#4 ~AS+IjerIUrIj362v885+IjAhK__5X%nV%Iͳ-y|7XV2v4fzo_68"S/I-qbf; LkF)KSM$ Ms>K WNV}^`-큧32ŒVؙGdu,^^m%6~Nn&͓3ŒVZMsRpfEW%IwdǀLm[7W&bIRL@Q|)* i ImsIMmKmyV`i$G+R 0tV'!V)֏28vU7͒vHꦼtxꗞT ;S}7Mf+fIRHNZUkUx5SAJㄌ9MqμAIRi|j5)o*^'<$TwI1hEU^c_j?Е$%d`z cyf,XO IJnTgA UXRD }{H}^S,P5V2\Xx`pZ|Yk:$e ~ @nWL.j+ϝYb퇪bZ BVu)u/IJ_ 1[p.p60bC >|X91P:N\!5qUB}5a5ja `ubcVxYt1N0Zzl4]7­gKj]?4ϻ *[bg$)+À*x쳀ogO$~,5 زUS9 lq3+5mgw@np1sso Ӻ=|N6 /g(Wv7U;zωM=wk,0uTg_`_P`uz?2yI!b`kĸSo+Qx%!\οe|އԁKS-s6pu_(ֿ$i++T8=eY; צP+phxWQv*|p1. ά. XRkIQYP,drZ | B%wP|S5`~́@i޾ E;Չaw{o'Q?%iL{u D?N1BD!owPHReFZ* k_-~{E9b-~P`fE{AܶBJAFO wx6Rox5 K5=WwehS8 (JClJ~ p+Fi;ŗo+:bD#g(C"wA^ r.F8L;dzdIHUX݆ϞXg )IFqem%I4dj&ppT{'{HOx( Rk6^C٫O.)3:s(۳(Z?~ٻ89zmT"PLtw䥈5&b<8GZ-Y&K?e8,`I6e(֍xb83 `rzXj)F=l($Ij 2*(F?h(/9ik:I`m#p3MgLaKjc/U#n5S# m(^)=y=đx8ŬI[U]~SцA4p$-F i(R,7Cx;X=cI>{Km\ o(Tv2vx2qiiDJN,Ҏ!1f 5quBj1!8 rDFd(!WQl,gSkL1Bxg''՞^ǘ;pQ P(c_ IRujg(Wz bs#P­rz> k c&nB=q+ؔXn#r5)co*Ũ+G?7< |PQӣ'G`uOd>%Mctz# Ԫڞ&7CaQ~N'-P.W`Oedp03C!IZcIAMPUۀ5J<\u~+{9(FbbyAeBhOSܳ1 bÈT#ŠyDžs,`5}DC-`̞%r&ڙa87QWWp6e7 Rϫ/oY ꇅ Nܶըtc!LA T7V4Jsū I-0Pxz7QNF_iZgúWkG83 0eWr9 X]㾮݁#Jˢ C}0=3ݱtBi]_ &{{[/o[~ \q鯜00٩|cD3=4B_b RYb$óBRsf&lLX#M*C_L܄:gx)WΘsGSbuL rF$9';\4Ɍq'n[%p.Q`u hNb`eCQyQ|l_C>Lb꟟3hSb #xNxSs^ 88|Mz)}:](vbۢamŖ࿥ 0)Q7@0=?^k(*J}3ibkFn HjB׻NO z x}7p 0tfDX.lwgȔhԾŲ }6g E |LkLZteu+=q\Iv0쮑)QٵpH8/2?Σo>Jvppho~f>%bMM}\//":PTc(v9v!gոQ )UfVG+! 35{=x\2+ki,y$~A1iC6#)vC5^>+gǵ@1Hy٪7u;p psϰu/S <aʸGu'tD1ԝI<pg|6j'p:tպhX{o(7v],*}6a_ wXRk,O]Lܳ~Vo45rp"N5k;m{rZbΦ${#)`(Ŵg,;j%6j.pyYT?}-kBDc3qA`NWQū20/^AZW%NQ MI.X#P#,^Ebc&?XR tAV|Y.1!؅⨉ccww>ivl(JT~ u`ٵDm q)+Ri x/x8cyFO!/*!/&,7<.N,YDŽ&ܑQF1Bz)FPʛ?5d 6`kQձ λc؎%582Y&nD_$Je4>a?! ͨ|ȎWZSsv8 j(I&yj Jb5m?HWp=g}G3#|I,5v珿] H~R3@B[☉9Ox~oMy=J;xUVoj bUsl_35t-(ՃɼRB7U!qc+x4H_Qo֮$[GO<4`&č\GOc[.[*Af%mG/ ňM/r W/Nw~B1U3J?P&Y )`ѓZ1p]^l“W#)lWZilUQu`-m|xĐ,_ƪ|9i:_{*(3Gѧ}UoD+>m_?VPۅ15&}2|/pIOʵ> GZ9cmíتmnz)yߐbD >e}:) r|@R5qVSA10C%E_'^8cR7O;6[eKePGϦX7jb}OTGO^jn*媓7nGMC t,k31Rb (vyܴʭ!iTh8~ZYZp(qsRL ?b}cŨʊGO^!rPJO15MJ[c&~Z`"ѓޔH1C&^|Ш|rʼ,AwĴ?b5)tLU)F| &g٣O]oqSUjy(x<Ϳ3 .FSkoYg2 \_#wj{u'rQ>o;%n|F*O_L"e9umDds?.fuuQbIWz |4\0 sb;OvxOSs; G%T4gFRurj(֍ڑb uԖKDu1MK{1^ q; C=6\8FR艇!%\YÔU| 88m)֓NcLve C6z;o&X x59:q61Z(T7>C?gcļxѐ Z oo-08jہ x,`' ҔOcRlf~`jj".Nv+sM_]Zk g( UOPyεx%pUh2(@il0ݽQXxppx-NS( WO+轾 nFߢ3M<;z)FBZjciu/QoF 7R¥ ZFLF~#ȣߨ^<쩡ݛкvџ))ME>ώx4m#!-m!L;vv#~Y[đKmx9.[,UFS CVkZ +ߟrY٧IZd/ioi$%͝ب_ֶX3ܫhNU ZZgk=]=bbJS[wjU()*I =ώ:}-蹞lUj:1}MWm=̛ _ ¾,8{__m{_PVK^n3esw5ӫh#$-q=A̟> ,^I}P^J$qY~Q[ Xq9{#&T.^GVj__RKpn,b=`żY@^՝;z{paVKkQXj/)y TIc&F;FBG7wg ZZDG!x r_tƢ!}i/V=M/#nB8 XxЫ ^@CR<{䤭YCN)eKOSƟa $&g[i3.C6xrOc8TI;o hH6P&L{@q6[ Gzp^71j(l`J}]e6X☉#͕ ׈$AB1Vjh㭦IRsqFBjwQ_7Xk>y"N=MB0 ,C #o6MRc0|$)ف"1!ixY<B9mx `,tA>)5ػQ?jQ?cn>YZe Tisvh# GMމȇp:ԴVuږ8ɼH]C.5C!UV;F`mbBk LTMvPʍϤj?ԯ/Qr1NB`9s"s TYsz &9S%U԰> {<ؿSMxB|H\3@!U| k']$U+> |HHMLޢ?V9iD!-@x TIî%6Z*9X@HMW#?nN ,oe6?tQwڱ.]-y':mW0#!J82qFjH -`ѓ&M0u Uγmxϵ^-_\])@0Rt.8/?ٰCY]x}=sD3ojަЫNuS%U}ԤwHH>ڗjܷ_3gN q7[q2la*ArǓԖ+p8/RGM ]jacd(JhWko6ڎbj]i5Bj3+3!\j1UZLsLTv8HHmup<>gKMJj0@H%,W΃7R) ">c, xixј^ aܖ>H[i.UIHc U1=yW\=S*GR~)AF=`&2h`DzT󑓶J+?W+}C%P:|0H܆}-<;OC[~o.$~i}~HQ TvXΈr=b}$vizL4:ȰT|4~*!oXQR6Lk+#t/g lԁߖ[Jڶ_N$k*". xsxX7jRVbAAʯKҎU3)zSNN _'s?f)6X!%ssAkʱ>qƷb hg %n ~p1REGMHH=BJiy[<5 ǁJҖgKR*倳e~HUy)Ag,K)`Vw6bRR:qL#\rclK/$sh*$ 6덤 KԖc 3Z9=Ɣ=o>X Ώ"1 )a`SJJ6k(<c e{%kϊP+SL'TcMJWRm ŏ"w)qc ef꒵i?b7b('"2r%~HUS1\<(`1Wx9=8HY9m:X18bgD1u ~|H;K-Uep,, C1 RV.MR5άh,tWO8WC$ XRVsQS]3GJ|12 [vM :k#~tH30Rf-HYݺ-`I9%lIDTm\ S{]9gOڒMNCV\G*2JRŨ;Rҏ^ڽ̱mq1Eu?To3I)y^#jJw^Ńj^vvlB_⋌P4x>0$c>K†Aļ9s_VjTt0l#m>E-,,x,-W)سo&96RE XR.6bXw+)GAEvL)͞K4$p=Ũi_ѱOjb HY/+@θH9޼]Nԥ%n{ &zjT? Ty) s^ULlb,PiTf^<À] 62R^V7)S!nllS6~͝V}-=%* ʻ>G DnK<y&>LPy7'r=Hj 9V`[c"*^8HpcO8bnU`4JȪAƋ#1_\ XϘHPRgik(~G~0DAA_2p|J묭a2\NCr]M_0 ^T%e#vD^%xy-n}-E\3aS%yN!r_{ )sAw ڼp1pEAk~v<:`'ӭ^5 ArXOI驻T (dk)_\ PuA*BY]yB"l\ey hH*tbK)3 IKZ򹞋XjN n *n>k]X_d!ryBH ]*R 0(#'7 %es9??ښFC,ՁQPjARJ\Ρw K#jahgw;2$l*) %Xq5!U᢯6Re] |0[__64ch&_}iL8KEgҎ7 M/\`|.p,~`a=BR?xܐrQ8K XR2M8f ?`sgWS%" Ԉ 7R%$ N}?QL1|-эټwIZ%pvL3Hk>,ImgW7{E xPHx73RA @RS CC !\ȟ5IXR^ZxHл$Q[ŝ40 (>+ _C >BRt<,TrT {O/H+˟Pl6 I B)/VC<6a2~(XwV4gnXR ϱ5ǀHٻ?tw똤Eyxp{#WK qG%5],(0ӈH HZ])ג=K1j&G(FbM@)%I` XRg ʔ KZG(vP,<`[ Kn^ SJRsAʠ5xՅF`0&RbV tx:EaUE/{fi2;.IAwW8/tTxAGOoN?G}l L(n`Zv?pB8K_gI+ܗ #i?ޙ.) p$utc ~DžfՈEo3l/)I-U?aԅ^jxArA ΧX}DmZ@QLےbTXGd.^|xKHR{|ΕW_h] IJ`[G9{).y) 0X YA1]qp?p_k+J*Y@HI>^?gt.06Rn ,` ?);p pSF9ZXLBJPWjgQ|&)7! HjQt<| ؅W5 x W HIzYoVMGP Hjn`+\(dNW)F+IrS[|/a`K|ͻ0Hj{R,Q=\ (F}\WR)AgSG`IsnAR=|8$}G(vC$)s FBJ?]_u XRvύ6z ŨG[36-T9HzpW̞ú Xg큽=7CufzI$)ki^qk-) 0H*N` QZkk]/tnnsI^Gu't=7$ Z;{8^jB% IItRQS7[ϭ3 $_OQJ`7!]W"W,)Iy W AJA;KWG`IY{8k$I$^%9.^(`N|LJ%@$I}ֽp=FB*xN=gI?Q{٥4B)mw $Igc~dZ@G9K X?7)aK%݅K$IZ-`IpC U6$I\0>!9k} Xa IIS0H$I H ?1R.Чj:4~Rw@p$IrA*u}WjWFPJ$I➓/6#! LӾ+ X36x8J |+L;v$Io4301R20M I$-E}@,pS^ޟR[/s¹'0H$IKyfŸfVOπFT*a$I>He~VY/3R/)>d$I>28`Cjw,n@FU*9ttf$I~<;=/4RD~@ X-ѕzἱI$: ԍR a@b X{+Qxuq$IЛzo /~3\8ڒ4BN7$IҀj V]n18H$IYFBj3̵̚ja pp $Is/3R Ӻ-Yj+L;.0ŔI$Av? #!5"aʄj}UKmɽH$IjCYs?h$IDl843.v}m7UiI=&=0Lg0$I4: embe` eQbm0u? $IT!Sƍ'-sv)s#C0:XB2a w I$zbww{."pPzO =Ɔ\[ o($Iaw]`E).Kvi:L*#gР7[$IyGPI=@R 4yR~̮´cg I$I/<tPͽ hDgo 94Z^k盇΄8I56^W$I^0̜N?4*H`237}g+hxoq)SJ@p|` $I%>-hO0eO>\ԣNߌZD6R=K ~n($I$y3D>o4b#px2$yڪtzW~a $I~?x'BwwpH$IZݑnC㧄Pc_9sO gwJ=l1:mKB>Ab<4Lp$Ib o1ZQ@85b̍ S'F,Fe,^I$IjEdù{l4 8Ys_s Z8.x m"+{~?q,Z D!I$ϻ'|XhB)=…']M>5 rgotԎ 獽PH$IjIPhh)n#cÔqA'ug5qwU&rF|1E%I$%]!'3AFD/;Ck_`9 v!ٴtPV;x`'*bQa w I$Ix5 FC3D_~A_#O݆DvV?<qw+I$I{=Z8".#RIYyjǪ=fDl9%M,a8$I$Ywi[7ݍFe$s1ՋBVA?`]#!oz4zjLJo8$I$%@3jAa4(o ;p,,dya=F9ً[LSPH$IJYЉ+3> 5"39aZ<ñh!{TpBGkj}Sp $IlvF.F$I z< '\K*qq.f<2Y!S"-\I$IYwčjF$ w9 \ߪB.1v!Ʊ?+r:^!I$BϹB H"B;L'G[ 4U#5>੐)|#o0aڱ$I>}k&1`U#V?YsV x>{t1[I~D&(I$I/{H0fw"q"y%4 IXyE~M3 8XψL}qE$I[> nD?~sf ]o΁ cT6"?'_Ἣ $I>~.f|'!N?⟩0G KkXZE]ޡ;/&?k OۘH$IRۀwXӨ<7@PnS04aӶp.:@\IWQJ6sS%I$e5ڑv`3:x';wq_vpgHyXZ 3gЂ7{{EuԹn±}$I$8t;b|591nءQ"P6O5i }iR̈́%Q̄p!I䮢]O{H$IRϻ9s֧ a=`- aB\X0"+5"C1Hb?߮3x3&gşggl_hZ^,`5?ߎvĸ%̀M!OZC2#0x LJ0 Gw$I$I}<{Eb+y;iI,`ܚF:5ܛA8-O-|8K7s|#Z8a&><a&/VtbtLʌI$I$I$I$I$I$IRjDD%tEXtdate:create2022-05-31T04:40:26+00:00!Î%tEXtdate:modify2022-05-31T04:40:26+00:00|{2IENDB`Mini Shell

HOME


Mini Shell 1.0
DIR:/home/dna1981/mail/.spam/new/
Upload File :
Current File : /home/dna1981/mail/.spam/new/1647767834.M759456P30287.dna.dna-1981.com,S=12108,W=12367
Return-Path: <21130-14500-10614-4592-c.wilson=smithfamilycarpets.com@mail.markedly.digital>
Delivered-To: dna1981+spam@dna.dna-1981.com
Received: from dna.dna-1981.com
	by dna.dna-1981.com with LMTP
	id Lq69LBrxNmJPdgAAff7CYA
	(envelope-from <21130-14500-10614-4592-c.wilson=smithfamilycarpets.com@mail.markedly.digital>)
	for <dna1981+spam@dna.dna-1981.com>; Sun, 20 Mar 2022 04:17:14 -0500
Return-path: <21130-14500-10614-4592-c.wilson=smithfamilycarpets.com@mail.markedly.digital>
Envelope-to: c.wilson@smithfamilycarpets.com
Delivery-date: Sun, 20 Mar 2022 04:17:14 -0500
Received: from [45.85.90.209] (port=40196 helo=las.markedly.digital)
	by dna.dna-1981.com with esmtp (Exim 4.94.2)
	(envelope-from <21130-14500-10614-4592-c.wilson=smithfamilycarpets.com@mail.markedly.digital>)
	id 1nVrgS-0007qD-7f
	for c.wilson@smithfamilycarpets.com; Sun, 20 Mar 2022 04:17:14 -0500
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=markedly.digital;
 h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=simplevisionsolution@markedly.digital;
 bh=UEPUZWOWFD/GPI81bPeaPLug2F8=;
 b=ViUEMj58RaVTHuApwK2k8oX8GvpGF4CUjGCrXI8TsHR2tBQzV0bAV8GcJcBi4I8GeJysBpzozSlG
   Ia5q53mzbIfu1THn9WAWvZ0kSLzvGrt6TZxVkYlA2C2oIVt8VV7uJb8P6Qr6IEibvBba/QcbpU1W
   cNA0JtOgU+ApTtUL29c=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=markedly.digital;
 b=SkcbNLVt1fIE/BgNALy/eEr4SaxSrQ038x0pzBjWQBWK3FlAoUfIJ11/CoNM/GyT4mwFiLQFNFlk
   OpF30LTBGrhIROnr0JGcbxgItcOfWdX90rziFZGWudFmKHjBQ7SZXyxYXk3wW7SqP77pIiSLhaWe
   pNECpHrBz44VGwgLRjc=;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="fc348c3b62ffcaf2cc0810fa67ff2aef"
Date: Sun, 20 Mar 2022 10:15:56 +0100
From: "Matthew" <simplevisionsolution@markedly.digital>
Reply-To: "Matthew" <simplevisionsolution@markedly.digital>
To: <c.wilson@smithfamilycarpets.com>
Message-ID: <t4b2iwgo9k98qrja-3f50anco6zvbcyop-2976@markedly.digital>
X-Spam-Status: Yes, score=33.2
X-Spam-Score: 332
X-Spam-Bar: +++++++++++++++++++++++++++++++++
X-Spam-Report: Spam detection software, running on the system "dna.dna-1981.com",
 has identified this incoming email as possible spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  This email must be viewed in HTML mode. Unbelievable! Yale
    scientists agreed, without exception, that vision problems are not caused
    by genetics or aging... 
 Content analysis details:   (33.2 points, 4.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  5.0 BAYES_99               BODY: Bayes spam probability is 99 to 100%
                             [score: 1.0000]
  1.0 BAYES_999              BODY: Bayes spam probability is 99.9 to 100%
                             [score: 1.0000]
  2.7 RCVD_IN_PSBL           RBL: Received via a relay in PSBL
                             [45.85.90.209 listed in psbl.surriel.com]
  4.5 URIBL_DBL_SPAM         Contains a spam URL listed in the Spamhaus DBL
                             blocklist
                             [URIs: markedly.digital]
  1.2 URIBL_ABUSE_SURBL      Contains an URL listed in the ABUSE SURBL
                             blocklist
                             [URIs: markedly.digital]
  5.0 URIBL_BLACK            Contains an URL listed in the URIBL blacklist
                             [URIs: markedly.digital]
  1.3 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in
                             bl.spamcop.net
                [Blocked - see <https://www.spamcop.net/bl.shtml?45.85.90.209>]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or
                             identical to background
  0.1 MIME_HTML_MOSTLY       BODY: Multipart message mostly text/html MIME
  0.8 MPART_ALT_DIFF         BODY: HTML and text parts are different
  0.0 HTML_MESSAGE           BODY: HTML included in message
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
 -0.1 DKIM_VALID_EF          Message has a valid DKIM or DK signature from
                             envelope-from domain
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from
                             author's domain
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
  0.9 RAZOR2_CHECK           Listed in Razor2 (http://razor.sf.net/)
  1.9 RAZOR2_CF_RANGE_51_100 Razor2 gives confidence level above 50%
                             [cf: 100]
  2.0 RDNS_NONE              Delivered to internal network by a host with no rDNS
 -0.0 T_SCC_BODY_TEXT_LINE   No description available.
  5.0 KAM_VERY_BLACK_DBL     Email that hits both URIBL Black and Spamhaus
                              DBL
  1.2 FSL_BULK_SIG           Bulk signature with no Unsubscribe
  0.7 NORDNS_LOW_CONTRAST    No rDNS + hidden text
  0.0 T_REMOTE_IMAGE         Message contains an external image
X-Spam-Flag: YES
Subject:    The Most Harmful Toxin For Your Eyes (Hint: It Causes Blindness)

--fc348c3b62ffcaf2cc0810fa67ff2aef
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit

This email must be viewed in HTML mode.

--fc348c3b62ffcaf2cc0810fa67ff2aef
Content-Type: text/html;
Content-Transfer-Encoding: 8bit

<html lang="en">
<head>
	<title></title>
</head>
<body><a href="http://markedly.digital/IC1OHnD-U0-99lO3BYAPIVcVjd9tm3kGL0GhaykMUHuCqYq3"><img border="0" src="http://markedly.digital/b9qwBIOtQ7x-5ONFl-z-oRcu7uDJzbMwZ6JIbwMltzdkl9mO" /> </a>
<table border="0" cellpadding="0" cellspacing="0" style="padding:0;margin:0 auto;" width="100%">
	<tbody>
		<tr>
			<td align="center" style="padding:0;margin:0 auto;" valign="top">
			<table align="center" border="0" cellpadding="0" cellspacing="0" style="padding:0;margin:0 auto; " width="650">
			</table>

			<table cellpadding="0" cellspacing="0" style="border: solid 4px #000000; " width="650">
				<tbody>
					<tr>
						<td>
						<table align="center" border="0" cellpadding="0" cellspacing="0" style="border: 0px solid #F4C88C;" width="100%">
							<tbody>
								<tr>
									<td style="padding:20px; font-size:18px; line-height:20px;">
									<div style="font-family: 'Book Antiqua',Palatino,'Palatino Linotype','Palatino LT STD',Georgia,serif;font-size:18px; line-height:150%;display:inline;border-collapse:collapse;">
									<p style="font-family: 'Book Antiqua',Palatino,'Palatino Linotype','Palatino LT STD',Georgia,serif; color:#090909;font-size:18px; line-height:130%;display:inline;border-collapse:separate;">Unbelievable!<br />
									<br />
									Yale scientists agreed, without exception, that vision problems are not caused by genetics or aging...<br />
									<br />
									But, by these <strong><a href="http://markedly.digital/sIw00SuV7xt3Y_jcxgHGr_7oQf73vpbt0Ppm4OUHXGeyTLc">dangerous micro fat clogs </a></strong><a href="http://markedly.digital/sIw00SuV7xt3Y_jcxgHGr_7oQf73vpbt0Ppm4OUHXGeyTLc"> </a>that actually suffocate your eyes...<br />
									<br />
									And which increases the risk of blindness by 91%!<br />
									<br />
									Anyone over the age of 50 is at risk, as glasses can do nothing to stop this...<br />
									<br />
									<strong>==&gt; <a href="http://markedly.digital/sIw00SuV7xt3Y_jcxgHGr_7oQf73vpbt0Ppm4OUHXGeyTLc">Click here to find out how to stop the micro fat clogs from damaging your vision</a></strong><a href="http://markedly.digital/sIw00SuV7xt3Y_jcxgHGr_7oQf73vpbt0Ppm4OUHXGeyTLc"> </a><br />
									&nbsp;</p>

									<p align="left"><a href="http://markedly.digital/sIw00SuV7xt3Y_jcxgHGr_7oQf73vpbt0Ppm4OUHXGeyTLc"><img src="http://markedly.digital/8cb95d4f8ba975e227.jpg" /> </a></p>
									</div>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table>

<table align="center" border="0" cellpadding="0" cellspacing="0" style="padding:0;margin:0 auto; border:solid 0px #FFFFFF;" width="600">
	<tbody>
		<tr>
			<td align="center" style="padding:0px 5px; font-family:Cambria, 'Hoefler Text', 'Liberation Serif', Times, 'Times New Roman', serif; text-align:center; margin:0 auto; font-size:12px;" valign="top" width="600">
			<p align="center"><br />
			<br />
			<br />
			<br />
			<br />
			&nbsp;</p>

			<div align="center" style="padding-top:55px; font-size:18px; font-family:Tahoma, Geneva, sans-serif; width:; text-align:center;"><a href="http://markedly.digital/IWQSXPK4if_32_SE2YAAJeGnqQm8S-yB_qDL0lGEQxk-CErX"><img alt="Unlist Here" src="http://markedly.digital/d2f335fb2e9ab1110e.jpg" /> </a><br />
			<br />
			<br />
			<br />
			<br />
			<br />
			&nbsp;</div>

			<p>&nbsp;</p>
			</td>
		</tr>
	</tbody>
</table>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
&nbsp;
<table align="center" class="dm">
	<tbody>
		<tr>
			<td colspan="2" style="background-color:#ffffff">
			<p><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; ">The enactment of orphan drug legislation in some countries has increased funding available to develop drugs meant to treat rare conditions, resulting in breakthroughs that previously were uneconomical to pursue. Since the establishment of the National Institutes of Health (NIH) in the mid-1940s, the main source of U.S. federal support of biomedical research, </span></p>

			<p><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; ">priorities and levels of funding have fluctuated. From 1995 to 2010, NIH support of biomedical research increased from 11 to 27  Despite the jump in federal spending, vancements measured by citations to publications and the number of drugs passed by the FDA remained stagnant over the same time span. Financial projections indicate federal spending will remain constant in the near future. US federal funding trends </span></p>

			<p><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; ">The National Institutes of Health (NIH) is the agency that is responsible for management of the lion&#39;s share of federal funding of biomedical research. It funds over 280 areas directly related to health. Over the past century t were two notable periods of NIH support. From 1995 to 1996 funding increased from $8.877 to $9.366, years which represented the </span></p>

			<p><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; ">start of what is considered the &quot;doubling period&quot; of rapid NIH support. The second notable period started in 1997 and ended in 2010, a period w the NIH moved to organize research spending for engagement with the scientific community. Privately (industry) funded biomedical research Further ination: industry-funded research </span></p>

			<p><span style="color:#fff; font-family:constantia,lucida bright,dejavu serif,georgia,serif; ">Since 1980 the share of biomedical research funding from industry sources has grown from 32% to 62%, which has resulted in the development of numerous-saving medical vances. The relationship between industry and government-funded research in the US has seen great movement over the years. The 1980 Bayh&ndash;Dole Act was passed by Congress to foster a more constructive </span></p>
			<br />
			<br />
			<br />
			&nbsp;</td>
		</tr>
	</tbody>
</table>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
&nbsp;
<p align="center"><a href="http://markedly.digital/QEP5xtHJRBPI1kIaLrcQLKX_g5I3QlSG5whqjRbk_kcElVo"><img src="http://markedly.digital/f949b000f8686f7a40.jpg" /></a></p>
</body>
</html>

--fc348c3b62ffcaf2cc0810fa67ff2aef--